Mobile

Study of Pregabalin (an Approved Drug) For the Treatment of Pain Associated with PHN, Conducted at Several Clinical Sites Where all Patients Enrolled Receive Pregabalin

Update Il y a 4 ans
Reference: EUCTR2011-005972-41

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to obtain pilot prospective data to explore whether sensory symptom cluster analysis is useful for predicting treatment response in PHN. - Phenotype PHN subjects entering study with sensory symptom clustering using the PainPREDICT, PainDETECT and NPSI questionnaires, “baseline pain interference with sleep”, Patient Health Questionnaire 8 (PHQ-8), Generalized Anxiety Disorder 7-item (GAD-7), as well as Pain Catastrophizing Scale (PCS) questionnaire. - Find “responders” and “non-responders” to treatment (pregabalin). - Compare distribution of phenotypes within “responder” and “non-responder” groups.

Inclusion criteria

  • Postherpetic Neuralgia (PHN)

Links